Pegaptanib was effective and safe without a dose-response relation in neovascular, age-related, macular degeneration
- PMID: 15989306
Pegaptanib was effective and safe without a dose-response relation in neovascular, age-related, macular degeneration
Comment on
-
Pegaptanib for neovascular age-related macular degeneration.N Engl J Med. 2004 Dec 30;351(27):2805-16. doi: 10.1056/NEJMoa042760. N Engl J Med. 2004. PMID: 15625332 Clinical Trial.